Rockefeller Capital Management L.P. Compass Pathways PLC Transaction History

Rockefeller Capital Management L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$6.76 - $14.18 $6,760 - $14,180	-1,000 Reduced 5.75%	16,400 $177,000
Q1 2022 May 13, 2022	BUY	$11.13 - $23.04 $82,362 - $170,496	7,400 Added 74.0%	17,400 $224,000
Q4 2021 Feb 14, 2022	BUY	$21.81 - $48.96 $152,997 - $343,454	7,015 Added 235.01%	10,000 $221,000
Q3 2021 Nov 12, 2021	SELL	$29.03 - $38.62 $87,090 - $115,859	-3,000 Reduced 50.13%	2,985 $89,000
Q2 2021 Aug 10, 2021	BUY	$32.29 - $39.68 $65,710 - $80,748	2,035 Added 51.52%	5,985 $228,000
Q1 2021 May 11, 2021	BUY	$34.75 - $57.5 $130,312 - $215,625	3,750 Added 1875.0%	3,950 $145,000
Q4 2020 Feb 12, 2021	BUY	$32.0 - $59.2 $6,400 - $11,840	200 New	200 $9,000

151

33.6M

536K

582K

Ticker CMPS
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 42,522,400
Market Cap $363M
Description
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.